Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liala Moschetti

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The Lancet. Rheumatology|August 25, 2020
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case-control studyMicaela Fredi, Ilaria Cavazzana, Liala Moschetti, et al.
Clinical and Experimental Rheumatology|February 10, 2023
Anti-Th/To antibodies in systemic sclerosis: analysis of long-term follow-up of pulmonary involvement, organ damage accrual and mortality in an Italian cohort with a case-control studyLiala Moschetti, Maria Grazia Lazzaroni, Ilaria Cavazzana, et al.
Clinical and Experimental Rheumatology|November 7, 2023
Long-term organ damage accrual and late mortality in systemic sclerosisMaria Grazia Lazzaroni, Liala Moschetti, Marta Breda, et al.
Autoimmunity Reviews|August 27, 2023
Can anticoagulation be withdrawn in APS patients after aPL negativization?Maria J Cuadrado, Angela Tincani, Eugenia Enriquez Merayo, et al.
Frontiers in Medicine|April 25, 2022
Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular DiseasesLiala Moschetti, Silvia Piantoni, Enrico Vizzardi, et al.
Clinical and Experimental Rheumatology|February 20, 2025
Frailty assessment in patients with systemic sclerosisClaudia Barison, Elda Piovani, Liala Moschetti, et al.
Expert Opinion on Drug Safety|February 18, 2021
Safety considerations when using drugs in pregnant patients with systemic lupus erythematosusAnna Viola Taulaigo, Liala Moschetti, Sara Ganhão, et al.
Reumatismo|August 18, 2025
The use of tumor necrosis factor inhibitors during high-risk pregnancies in antiphospholipid syndrome: a clinical report of a patient with concomitant Takayasu arteritis and case-based reviewLiala Moschetti, Francesca Crisafulli, Francesca Regola, et al.
Healthcare (Basel, Switzerland)|May 4, 2026
Lupus Remission: How Do Patient and Physician Perceptions Align?Chiara Orlandi, Micaela Fredi, Cesare Tomasi, et al.
Journal of Scleroderma and Related Disorders|February 27, 2025
The impact of systemic sclerosis on women's health evaluated with an ad hoc-developed patient-reported questionnaireMaria-Grazia Lazzaroni, Liala Moschetti, Eleonora Pedretti, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Lancet. Rheumatology|August 25, 2020
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case-control studyMicaela Fredi, Ilaria Cavazzana, Liala Moschetti, et al.
Clinical and Experimental Rheumatology|February 10, 2023
Anti-Th/To antibodies in systemic sclerosis: analysis of long-term follow-up of pulmonary involvement, organ damage accrual and mortality in an Italian cohort with a case-control studyLiala Moschetti, Maria Grazia Lazzaroni, Ilaria Cavazzana, et al.
Clinical and Experimental Rheumatology|November 7, 2023
Long-term organ damage accrual and late mortality in systemic sclerosisMaria Grazia Lazzaroni, Liala Moschetti, Marta Breda, et al.
Autoimmunity Reviews|August 27, 2023
Can anticoagulation be withdrawn in APS patients after aPL negativization?Maria J Cuadrado, Angela Tincani, Eugenia Enriquez Merayo, et al.
Frontiers in Medicine|April 25, 2022
Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular DiseasesLiala Moschetti, Silvia Piantoni, Enrico Vizzardi, et al.
Clinical and Experimental Rheumatology|February 20, 2025
Frailty assessment in patients with systemic sclerosisClaudia Barison, Elda Piovani, Liala Moschetti, et al.
Expert Opinion on Drug Safety|February 18, 2021
Safety considerations when using drugs in pregnant patients with systemic lupus erythematosusAnna Viola Taulaigo, Liala Moschetti, Sara Ganhão, et al.
Reumatismo|August 18, 2025
The use of tumor necrosis factor inhibitors during high-risk pregnancies in antiphospholipid syndrome: a clinical report of a patient with concomitant Takayasu arteritis and case-based reviewLiala Moschetti, Francesca Crisafulli, Francesca Regola, et al.
Healthcare (Basel, Switzerland)|May 4, 2026
Lupus Remission: How Do Patient and Physician Perceptions Align?Chiara Orlandi, Micaela Fredi, Cesare Tomasi, et al.
Journal of Scleroderma and Related Disorders|February 27, 2025
The impact of systemic sclerosis on women's health evaluated with an ad hoc-developed patient-reported questionnaireMaria-Grazia Lazzaroni, Liala Moschetti, Eleonora Pedretti, et al.
Pageof 2